US Stock MarketDetailed Quotes

VRDN Viridian Therapeutics

Watchlist
  • 21.000
  • -0.550-2.55%
Close Dec 2 16:00 ET
  • 21.000
  • 0.0000.00%
Post 16:28 ET
1.66BMarket Cap-4861P/E (TTM)

Viridian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Viridian Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 50.000K--
--2024/Q4-- / 48.770K--
--2024/Q386.000K / 49.580K--
--2024/Q272.000K / 91.690K--
May 8, 20242024/Q172.000K / 79.830K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 50.000K--
--2024/Q4-- / 48.770K--
--2024/Q386.000K / 49.580K--
--2024/Q272.000K / 91.690K--
May 8, 20242024/Q172.000K / 79.830K--

Unlock Free Earnings Estimates

Viridian Therapeutics Earnings Reports

  • Viridian Therapeutics | 8-K: Viridian Therapeutics Reports Third Quarter 2024 Financial Results and Recent Progress Including New FcRn Data

    Nov 12 09:31 ET

  • Viridian Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 12 09:31 ET

  • Viridian Therapeutics | 8-K: Viridian Therapeutics Highlights Recent Progress and Reports Second Quarter 2024 Financial Results

    Aug 8 08:29 ET

  • Viridian Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 08:04 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      93.33%

    • Hold

      6.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data